The same regulatory effect was shown in CRC cell lines, where knockdown of ALKBH2 inhibited CRC cells’ proliferation and invasive capacity by increasing E-cadherin and decreasing N-cadherin expression. Here, ALKBH2 is linked to colorectal carcinoma.